Page 2 - Nasdaq Grcl News Today

Gracell Biotechnologies Inc. (NASDAQ:GRCL – Get Free Report) saw unusually-high trading volume on Wednesday . Approximately 1,041,405 shares changed hands during trading, an increase of 144% from the previous session’s volume of 426,147 shares.The stock last traded at $9.90 and had previously closed at $9.92. Wall Street Analysts Forecast Growth Several research analysts recently commented […]

Sphera Funds Management LTD. lessened its stake in shares of Gracell Biotechnologies Inc. (NASDAQ:GRCL – Free Report) by 48.0% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,228,665 shares of the company’s stock after selling 1,131,915 shares during the quarter. Sphera Funds Management […]

SAN DIEGO and SUZHOU, China and SHANGHAI, China, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. (

Gracell Biotechnologies (NASDAQ:GRCL – Free Report) had its target price decreased by Citigroup from $12.00 to $11.00 in a research note issued to investors on Tuesday morning, Benzinga reports. Citigroup currently has a buy rating on the stock. Other equities analysts have also issued reports about the stock. BTIG Research raised their target price on […]

Gracell Biotechnologies Inc. (NASDAQ:GRCL – Get Free Report) was the recipient of a significant increase in short interest in August. As of August 15th, there was short interest totalling 799,100 shares, an increase of 6.8% from the July 31st total of 748,300 shares. Currently, 1.0% of the company’s stock are short sold. Based on an […]

Cantor Fitzgerald reaffirmed their overweight rating on shares of Gracell Biotechnologies (NASDAQ:GRCL – Free Report) in a research note released on Wednesday, Benzinga reports. Cantor Fitzgerald currently has a $20.00 price objective on the stock. A number of other analysts also recently issued reports on GRCL. Citigroup dropped their price target on shares of Gracell […]

Gracell Biotechnologies (NASDAQ:GRCL – Get Free Report) is scheduled to be announcing its earnings results before the market opens on Monday, August 14th. Analysts expect the company to announce earnings of ($0.37) per share for the quarter. Individual that wish to register for the company’s earnings conference call can do so using this link. Gracell […]

Gracell Biotechnologies Inc. (NASDAQ:GRCL – Get Rating) – Analysts at HC Wainwright decreased their Q2 2023 earnings estimates for Gracell Biotechnologies in a research note issued on Monday, May 15th. HC Wainwright analyst E. Bodnar now anticipates that the company will post earnings per share of ($0.41) for the quarter, down from their prior forecast […]

Gracell Biotechnologies Inc. (NASDAQ:GRCL – Get Rating) was the recipient of a large decline in short interest during the month of April. As of April 15th, there was short interest totalling 391,200 shares, a decline of 9.2% from the March 31st total of 430,800 shares. Based on an average daily trading volume, of 325,100 shares, […]

Gracell Biotechnologies Inc. (NASDAQ:GRCL – Get Rating) saw a large growth in short interest during the month of March. As of March 31st, there was short interest totalling 430,800 shares, a growth of 14.8% from the March 15th total of 375,400 shares. Currently, 0.7% of the shares of the company are sold short. Based on […]